Concepedia
Statistics
Publications
45
Citations
3.1K
H-Index
29
Active since
2017
Affiliations
East Carolina University(Current)
Imperial College London
The University of Texas MD Anderson Cancer Center
National Cancer Institute
The University of Kansas Cancer Center
Abdul Rafeh Naqash is an author at East Carolina University specializing in medicine, oncology, and pathology.
Top concepts
MedicineOncologyPathologyImmunologyCancer TherapyLung CancerImmunotherapyCancer ResearchMolecular OncologyRadiation Oncology
Publications per year
2017–2025
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer
Bairavi Shankar, Jiajia Zhang, Abdul Rafeh Naqash et al. · JAMA Oncology · 2020 · 472 citations · Full text
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
Chipman Stroud, Aparna Hegde, Cynthia R. Cherry et al. · Journal of Oncology Pharmacy Practice · 2017 · 316 citations
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study
Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida et al. · Hepatology · 2022 · 218 citations · Full text
Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
Hamzah Abu‐Sbeih, Faisal S. Ali, Abdul Rafeh Naqash et al. · Journal of Clinical Oncology · 2019 · 192 citations · Full text
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
Hamzah Abu‐Sbeih, David M. Faleck, Biagio Ricciuti et al. · Journal of Clinical Oncology · 2019 · 188 citations · Full text
Rows per page
1–5 of 45